We identify and license promising early-stage therapeutic programs and advance them through rigorous discovery and translational development to reach key value inflection points such as IND filing and early clinical proof-of-concept. By executing programs efficiently and with scientific discipline in India, we can pursue multiple high-quality opportunities, increasing the probability of success for both Anveta Therapeutics and our partners